Wai Chun Bio-Technology Ltd
00660
Company Profile
Business description
Wai Chun Bio-Technology Ltd is an investment holding company. The company has one reportable segmentbeing the manufacturing and sale of modified starch and other biochemical products. It is involved in the manufacturing and sale of modified starch and other biochemical products. Geographically, it derives a majority of its revenue from the People's Republic of China. The company also has its presence in Hong Kong.
Contact
26 Harbour Road
Rooms 4001-02, 40th Floor, China Resources Building
Wanchai
Hong Kong
HKGT: +852 31029989
Sector
Basic Materials
Stock type
Cyclical
Industry
Chemicals
Fiscal Year End
30 June 2026
Employees
61
Stocks News & Analysis
stocks
ASX healthcare giant remains well positioned despite share slump
We welcome the CEO change at CSL but relatively soft plasma performance will postpone recovery
stocks
Australian bank remains overvalued despite strong result
When strong fundamentals meet persistent valuation headwinds.
stocks
Chart of the Week: Soft earnings growth outlook for Australian banks
The latest take from our equity research analysts.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,312.10 | 11.00 | -0.12% |
| CAC 40 | 8,313.24 | 14.64 | -0.18% |
| DAX 40 | 24,856.15 | 131.70 | -0.53% |
| Dow JONES (US) | 50,121.40 | 66.74 | -0.13% |
| FTSE 100 | 10,472.11 | 118.27 | 1.14% |
| HKSE | 27,266.38 | 83.23 | 0.31% |
| NASDAQ | 23,066.47 | 36.01 | -0.16% |
| Nikkei 225 | 57,849.82 | 199.28 | 0.35% |
| NZX 50 Index | 13,537.14 | 29.86 | 0.22% |
| S&P 500 | 6,941.47 | 0.34 | -0.00% |
| S&P/ASX 200 | 9,069.20 | 7.20 | 0.08% |
| SSE Composite Index | 4,131.57 | 0.42 | -0.01% |